Testing for C. difficile is indicated in patients with diarrhea, especially after antibiotic use or healthcare exposure. Early testing facilitates prompt diagnosis and management, influencing ...
A new study published today in the American Journal of Infection Control (AJIC) describes the outcome of a new approach to testing for Clostridioides difficile (C. diff) guided by the principles of ...
An EMR-based alert helped reduce unnecessary orders for testing for Clostridioides difficile infection in hospitals, according to a study published in Infection Control & Hospital Epidemiology.
News-Medical.Net on MSN
Tufts researchers identify new vulnerabilities to combat persistent C. diff infections
Affecting roughly half a million Americans each year, bacterial infections caused by Clostridioides difficile —commonly known as C. diff —are a serious and persistent problem for patients and ...
56% Increase in C. diff Due in Part to Improved Detection Hospitals that switched Clostridium difficile testing from nonmolecular to molecular methods recorded a 56 percent increase in recorded C.
Please provide your email address to receive an email when new articles are posted on . Two-step testing was associated with a decrease in hospital-onset C. difficile infection. Similar decreases were ...
Please provide your email address to receive an email when new articles are posted on . Lewis and colleagues tested the three EHR-based interventions at three hospitals. The first intervention, ...
Singulex’s Clarity C. diff toxin A/B assay, a rapid C. diff toxin test, has made its commercial debut, the company announced. “The Clarity toxin A/B assay offers a new approach to testing for C. diff ...
Hospitals across the country are being challenged by diagnosing a contagious and deadly superbug. A local lab has a solution to the illness affecting hundreds of thousands of Americans. Clostridium ...
Great Basin Corporation Submits 510(K) Application to FDA for C. Difficile Molecular Diagnostic Test
SALT LAKE CITY--(BUSINESS WIRE)-- Great Basin Corporation, a privately held life sciences company developing sample-to-result molecular diagnostic solutions, today announced it has submitted a 510(k) ...
The CDC provides a free online video for healthcare providers on testing for Clostridium difficile. In the video, Dr. Carolyn Gould, a medical epidemiologist in the Division of Healthcare Quality ...
Dear Dr. Roach: I had two previous episodes of C. diff and was treated with vancomycin. My stool tests the first time were negative. Recently, I got the same symptoms, and the doctor did a stool test ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results